https://www.selleckchem.com/pr....oducts/orelabrutinib
5% vs 71%; P = .023) in patients ultimately diagnosed with infection. LIMITATIONS This study was conducted at a single institution, thereby restricting its broad applicability. The lack of a validated criterion standard to diagnose infection also limits interpretation of the results. CONCLUSION Tissue culture and histopathology often yield discordant results. Dermatologists should recognize specific limitations, yet high clinical utility in special circumstances, of tests when approaching cases of suspected infection. With the rap